Free Trial

Artiva Biotherapeutics (ARTV) SEC Filings & 10K Form

Artiva Biotherapeutics logo
$2.76 +0.12 (+4.55%)
Closing price 04:00 PM Eastern
Extended Trading
$2.73 -0.03 (-1.09%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Artiva Biotherapeutics SEC Filings

DateFilerForm TypeView
08/06/2025
4:16 PM
Artiva Biotherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/16/2025
6:02 PM
Artiva Biotherapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
06/26/2025
3:30 PM
Artiva Biotherapeutics (Issuer)
DANIELS BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:30 PM
Artiva Biotherapeutics (Issuer)
Miralles Gines Diego (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:30 PM
Artiva Biotherapeutics (Issuer)
Stoppel Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:30 PM
Artiva Biotherapeutics (Issuer)
HOUGEN ELIZABETH L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:30 PM
Artiva Biotherapeutics (Issuer)
Baker Daniel G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:30 PM
Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
3:02 PM
Artiva Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:03 AM
Artiva Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:06 AM
Artiva Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2025
8:34 PM
Artiva Biotherapeutics (Filer)
Form DEF 14A
04/28/2025
8:36 PM
Artiva Biotherapeutics (Filer)
Form DEFA14A
04/28/2025
8:43 PM
Artiva Biotherapeutics (Filer)
Form ARS
04/23/2025
7:14 PM
Artiva Biotherapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G
03/24/2025
3:09 PM
Artiva Biotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
3:35 PM
Artiva Biotherapeutics (Issuer)
Aslan Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:15 PM
Artiva Biotherapeutics (Issuer)
Bush Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:15 PM
Artiva Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:15 PM
Artiva Biotherapeutics (Issuer)
Horan Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:15 PM
Artiva Biotherapeutics (Issuer)
Graef Thorsten (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:15 PM
Artiva Biotherapeutics (Issuer)
Raymon Heather (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:32 PM
Artiva Biotherapeutics (Issuer)
Baker Daniel G. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/29/2025
3:33 PM
Artiva Biotherapeutics (Issuer)
Baker Daniel G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:07 PM
Artiva Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:56 PM
Artiva Biotherapeutics (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
Form SC 13G/A
10/22/2024
7:14 PM
Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/22/2024
7:18 PM
Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:13 PM
Artiva Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
3:16 PM
Artiva Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ARTV) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners